Philip H. Sossenheimer

Real-World Experience with Tofacitinib in IBD at a Tertiary Center

Roni Weisshof, Maya Aharoni Golan, Philip H. Sossenheimer et al. · Digestive Diseases and Sciences · 2019 · 102 citations

Translational Medicine, Tertiary Center, Medicine +2

Efficacy and safety of induction therapy with calcineurin inhibitors followed by vedolizumab maintenance in 71 patients with severe steroid‐refractory ulcerative colitis

Jacob E. Ollech, Sujaata Dwadasi, Victoria Rai et al. · Alimentary Pharmacology & Therapeutics · 2019 · 53 citations

Low-Dose Metronidazole is Associated With a Decreased Rate of Endoscopic Recurrence of Crohn’s Disease After Ileal Resection: A Retrospective Cohort Study

Laura Glick, Philip H. Sossenheimer, Jacob E. Ollech et al. · Journal of Crohn s and Colitis · 2019 · 50 citations · Full text

Cumulative Histologic Inflammation Predicts Colorectal Neoplasia in Ulcerative Colitis: A Validation Study

Olivia Yvellez, Victoria Rai, Philip H. Sossenheimer et al. · Inflammatory Bowel Diseases · 2020 · 40 citations · Full text

Structural Violence and Trauma Outcomes: An Ethical Framework for Practical Solutions

Philip H. Sossenheimer, Michael J. Andersen, Max H. Clermont et al. · Journal of the American College of Surgeons · 2018 · 37 citations